Ionis Pharmaceuticals, Inc.
Price Action
Technical Summary
WEAKENINGIonis Pharmaceuticals, Inc. is in a technical downtrend, trading below key resistance levels with a broken trend structure. Relative strength is weak (RS Rating: 45), showing significant lag compared to the market leaders. Earnings growth of 40% provides fundamental context to the price action. A decisive close above the 200-day moving average is required to signal a potential trend reversal.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $74.68 | -0.74% | BELOW |
| 50 SMA | $74.90 | -1.03% | BELOW |
| 100 SMA | $76.54 | -3.16% | BELOW |
| 150 SMA | $77.35 | -4.18% | BELOW |
| 200 SMA | $75.00 | -1.17% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is IONS in an uptrend right now?
IONS has a trend score of 1/4 based on Minervini's Stage Analysis. Currently showing broken structure - 1 of 4 trend criteria are met.
Is IONS overbought or oversold?
IONS's RSI (14) is 49. The stock is in neutral territory, neither overbought nor oversold.
Is IONS outperforming the market?
IONS has a Relative Strength (RS) Rating of 45 out of 99. IONS is currently lagging the broader market.
Where is IONS in its 52-week range?
IONS is trading at $74.12, which is 85% of its 52-week high ($86.74) and 75% above its 52-week low ($36.93).
How volatile is IONS?
IONS has a Beta of 0.43 and 52-week volatility of 47%. It's less volatile than the S&P 500 - generally more stable.